Or...Enter your Email


Useful Sites




Are you currently insured?
Yes No
First Name:
Last Name:
Zip Code:

  • National Debt Clock






PerkinElmer, Inc. (PKI) Selected by Mexican Ministry of Health to Provide Newborn Screenings

Source: http://Blog.QualityStocks.net
Posted on Friday, August 1st, 2008 | In Market Commentary, OTCBB Markets, Small & Micro Cap, Stocks to Watch
Contributed by: QualityStocks (http://QualityStocks.net) -

PerkinElmer, Inc. (PKI) provides products and services relative to neonatal screens, prenatal screening and maternal health. Based in Waltham, Massachusetts, the company designs, manufactures, and markets service products and systems within two business units: Life and Analytical Sciences and Optoelectronics.

The Life and Analytical Sciences unit provides precision instrumentation, reagents and chemistries, software and services for a wide range of scientific and industrial laboratory applications, including genetic screening, drug discovery and development, environmental monitoring, food and beverage quality, and chemical analysis. The Optoelectronics unit provides digital imaging, sensor and specialty lighting components used in biomedical, consumer products and other specialty markets.

The company recently announced a one-year agreement with the Mexican Ministry of Health, La Secretaria de Salud to expand its newborn screening program across Mexico. Under the terms of the agreement, PerkinElmer will provide instrumentation, reagents and screening expertise that will help the Ministry screen for congenital hypothyroidism and triple its screen capacity. The expanded program began in May 2008.

In 2007, the company provided technology to screen approximately 640,000 newborns in 14 laboratories across Mexico. Under this new agreement, the number of screenings will increase to approximately 1.9 million tests per year. The Ministry will use the company’s DELFIA® and AutoDELFIA® Neonatal TSH (hTSH) kits, and VICTOR™ platform to screen for congenital hypothyroidism (CH) in newborns. CH is an inherited metabolic disorder which occurs in 1 in 3,000-6,000 babies worldwide. Untreated, CH can lead to severe mental retardation.

Let us hear your thoughts below:

Last 5 posts by QualityStocks





About QualityStocks (http://QualityStocks.net)

Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis.

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

Leave a Reply

Name

Email (kept private)

Website




Custom Search







Related Posts

»Natus Medical Inc. (BABY) is “One to Watch”
»Universal health care in China
»Do you have S$9k in your Medisave?

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.